×
Envista Holdings EBIT 2018-2024 | NVST
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Envista Holdings ebit from 2018 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Envista Holdings EBIT 2018-2024 | NVST
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Envista Holdings ebit from 2018 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$194.8B
Boston Scientific (BSX)
$139.8B
Stryker (SYK)
$139.4B
EssilorLuxottica (ESLOY)
$110.1B
Medtronic (MDT)
$103.4B
Lonza Group Ag (LZAGY)
$43.7B
Haleon (HLN)
$41.2B
GE HealthCare Technologies (GEHC)
$38.7B
ResMed (RMD)
$34.3B
Terumo (TRUMY)
$28B
Koninklijke Philips (PHG)
$24.3B
Zimmer Biomet Holdings (ZBH)
$20.8B
Insulet (PODD)
$19.1B
Baxter (BAX)
$15B
Smith & Nephew SNATS (SNN)
$10.5B
Bio-Rad Laboratories (BIO)
$9.6B
BellRing Brands (BRBR)
$9.1B
Demant (WILYY)
$8.6B
Lantheus Holdings (LNTH)
$6.7B
Haemonetics (HAE)
$3.9B
ICU Medical (ICUI)
$3.8B
Prestige Consumer Healthcare (PBH)
$3.7B
Perrigo (PRGO)
$3.3B
QuidelOrtho (QDEL)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
Neogen (NEOG)
$2.7B
GN Store Nord (GNNDY)
$2.6B
LeMaitre Vascular (LMAT)
$2.1B
Green Thumb Industries (GTBIF)
$1.6B
AtriCure (ATRC)
$1.5B